MANAN SPINAL NEEDLES

K983620 · Manan Medical Products, Inc. · BSP · Jan 8, 1999 · Anesthesiology

Device Facts

• Record ID: K983620
• Device Name: MANAN SPINAL NEEDLES
• Applicant: Manan Medical Products, Inc.
• Product Code: BSP · Anesthesiology
• Decision Date: Jan 8, 1999
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 868.5150
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

For the spinal administration of anesthetic agents to elicit regional anesthesia.

Device Story

Spinal needle used by clinicians for delivery of anesthetic agents into spinal space to induce regional anesthesia. Device facilitates access to spinal region for therapeutic drug administration. Used in clinical settings by healthcare professionals. Output is physical delivery of anesthetic; clinical decision-making relies on physician assessment of patient need for regional anesthesia.

Clinical Evidence

Bench testing only; no clinical data provided.

Technological Characteristics

Spinal needle for regional anesthesia delivery. Mechanical device; no electronic components, software, or algorithms. Materials and sterilization methods consistent with standard medical needle manufacturing.

Indications for Use

Indicated for patients requiring regional anesthesia via spinal administration of anesthetic agents.

Regulatory Classification

Identification

An anesthesia conduction needle is a device used to inject local anesthetics into a patient to provide regional anesthesia.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized image of an eagle with its wings spread, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged in a circular pattern around the eagle. The eagle is depicted in black and white, and the text is also in black.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JAN 8 1999

Mr. Michael Plishka New Product Development Engineer Manan Medical Products, Inc. 2200 Carlson Drive Northbrook, IL 60062

Re: K983620 Manan Spinal Needles Regulatory Class: II (two) Product Code: 73 BSP Dated: October 14, 1998 Received: October 15, 1998

Dear Mr. Plishka:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Ouality System Requlation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

## Page 2 - Mr. Michael Plishka

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diaqnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other qeneral information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone], or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Thomas J. Callahan

Thomas J. I allahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

K983620 510(K) Number (if known):

Device Name:

Spinal Needle

Indications For Use:

For the spinal administration of anesthetic agents to elicit regional anesthesia.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use OR Over-The-Counter Use (Per 21 CFR 801.109) (Optional Format 1-2-96) (Division Sign-Off) Division of Cardiovascular, Re and Neurological Devices 510(k) Number